FIELD: biotechnology.
SUBSTANCE: method of reprogramming somatic mammalian cells is proposed, comprising bringing the mammalian somatic cell into contact with reprogramming factors selected from the group consisting of: (i) Oct4; (ii) Oct4 and Klf4; (iii) Oct4, Klf4 and Sox2, and with Wnt-conditioned medium or activator of the pathway Wnt.
EFFECT: invention can be used for obtaining induced pluripotent stem cells in order to treat or prevent a medical pathological state in an individual.
10 cl, 1 tbl, 5 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND PREPARATIONS FOR TRANSFECTION OF CELLS | 2012 |
|
RU2691027C2 |
| PERSONALISED PRODUCTION OF BIOPREPARATIONS AND STEM CELL REPROGRAMMING METHOD | 2012 |
|
RU2595390C2 |
| METHODS AND FORMULATIONS FOR CELLS TRANSFECTION | 2012 |
|
RU2624139C2 |
| METHOD OF PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS OF PATIENTS WITH DOWN SYNDROME | 2012 |
|
RU2492233C1 |
| METHOD OF PRODUCING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLASTS OF PATIENTS WITH HUNTINGTON'S DISEASE | 2011 |
|
RU2458983C1 |
| SOMATIC CELL REPROGRAMMING METHOD | 2008 |
|
RU2502799C2 |
| METHOD FOR INCREASING RNA EXPRESSION IN CELL | 2018 |
|
RU2784654C2 |
| TRANSIENT CELLULAR REPROGRAMMING TO REVERSE CELL AGING | 2019 |
|
RU2801316C2 |
| METHOD OF OBTAINING OF PATIENT (DONOR) - SPECIFIC FIBROBLAST-LIKE CELLS FROM INDUCED PLURIPOTENT HUMAN STEM CELLS | 2014 |
|
RU2568059C1 |
| METHOD FOR PRODUCING HIGH-QUALITY INDUCED PLURIPOTENT STEM CELLS (IPSC) | 2016 |
|
RU2721266C1 |
